CNBC Investing Club

Analyst loves Eli Lilly for its potential blockbuster obesity drug — and we do, too

The Eli Lilly logo is shown on one of the company's offices in San Diego, California, September 17, 2020.
Mike Blake | Reuters

More In Analysis

Top 5 and bottom 5 Club stocks between the S&P 500's old June low and Monday's new one
CNBC Investing ClubTop 5 and bottom 5 Club stocks between the S&P 500's old June low and Monday's new one
2 takeaways from our daily meeting: Possible Bullpen buys; doubling down on Salesforce, Ford
CNBC Investing Club2 takeaways from our daily meeting: Possible Bullpen buys; doubling down on Salesforce, Ford
These 9 stocks are less impacted by the strong U.S. dollar and are well-liked on the Street
CNBC Investing ClubThese 9 stocks are less impacted by the strong U.S. dollar and are well-liked on the Street